SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-011872
Filing Date
2023-05-01
Accepted
2023-05-01 16:01:40
Documents
20

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A opk20230404_def14a.htm   iXBRL DEF 14A 747156
6 finalopkproxycardpage1rdg.jpg GRAPHIC 307721
7 finalopkproxycardpage2rdg.jpg GRAPHIC 232103
8 netincome.jpg GRAPHIC 15932
9 revenue.jpg GRAPHIC 16782
10 sr.jpg GRAPHIC 3198
11 tsr.jpg GRAPHIC 15194
  Complete submission text file 0001437749-23-011872.txt   2809854

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA opk-20221231.xsd EX-101.SCH 5341
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20221231_def.xml EX-101.DEF 6010
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20221231_lab.xml EX-101.LAB 11314
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20221231_pre.xml EX-101.PRE 5593
14 EXTRACTED XBRL INSTANCE DOCUMENT opk20230404_def14a_htm.xml XML 105934
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33528 | Film No.: 23873443
SIC: 2834 Pharmaceutical Preparations